A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy by Thomas, A et al.
Vol. 60 No. 4 INDIAN JOURNAL OF LEPROSY October 1988
A DOUBLEBLIND CONTROLLED CLINICAL TRIAL TO ASSESS
THE ROLE OF ANTI-HISTAMINES IN THE TREATMENT OF MULTI-
BACILLARY LEPROSY
A. THOMAS1, M. NAGARAJAN 2, V. CHANDRASEKARAN3, LALITHA  HARI4,
P.R. SOMASUNDARAM5, R. PRABHAKAR6, ASHOK KUMAR7, V.N. BHATIA8
AND R.G. Roy9
ABSTRACT : A double blind controlled clinical trial to assess the role of anti-
histamines as a supplement in the treatment of leprosy was conducted in multi-
bacillary cases of leprosy.In all, 120 patients with lepromatous or borderline
leprosy were randomly allocated to a regimen of clofazimine and dapsone for
12 months with or without a supplement of pheniramine maleate for the first 3
months. During the 12-month period, 92% of the patients who received the
supplement and 86% of the patients who had not received it had moderate or
marked clinical improvement.The BI values decreased from 4.1 to 3.4 and 4.2
to 3.3, respectively.The results over the 12-month period showed that the addi-
tion of the antihistamine had not enhanced the efficacy of the regimen as evidenced
by clinical and bacteriological findings.
INTRODUCTION
Lepromatous leprosy represents the florid form of leprosy with a
well-defined immunological defect which appears to lie either in the macro-
phages or in the T-lymphocytes.Increased levels of immunoglobulins,
including IgE, are found in lepromatous patients (Jopling, 1984). It is
known that IgE releases histamine from mast cells and basophils on contact
with an antigen.
On the basis of experimental work in vitro, Veeraraghavan (1985)
suggested that release of histamine at the sites of immediate hypersensiti-
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vity reaction could possibly generate histamine-induced suppressor activity
by lymphocytes, which may play a regulatory role in the subsequent deve-
lopment of cellular immune response.Furthermore, it has been suggest-
ed by Veeraraghavan (1983) that histamine and heparin are growth-stimu-
lants for M. leprae and that histamine H-1 and H-2 receptor antagonists
have a marked inhibitory effect on the growth of the organisms in vitro.
It was reported that anti-histamines, particularly pheniramine maleate,
produced marked clinical and bacteriological improvement in lepromatous
leprosy patients (Gangadhara Sharma, 1982).Therefore, a controlled clini-
cal trial was conducted to evaluate the potential beneficial effect of pheni-
ramine maleate in the treatment of lepromatous or borderline lepromatous
leprosy patients. The results up to 12 months are reported here.
Aims and Objectives :To assess the effect of a supplement of pheni-
ramine maleate (anti-histamine) on the therapeutic efficacy of a regimen of
clofazimine and dapsone in the treatment of multibacillary leprosy.
MATERIALS AND METHODS
The study was conducted concurrently at two places, namely the
Leprosy Unit of the Tuberculosis Research Centre at the Govt. Royapettah
Hospital, Madras, and the Rural Field Operational Area of the Central
Leprosy Teaching and Research Institute, Thirumani, Chengalpattu, comp-
rising 54 villages in Sriperumbudur Taluk of Chengalpattu District, Tamil
Nadu.
Eligibility Criteria :Multibacillary leprosy patients aged 15 years
and above, who were classified clinically and histopathologically as BL or
LL type with a bacteriological index of 2.5 or more on Ridley’s scale (1964)
were included in the trial.Pregnant women and those suffering from
diseases such as tuberculosis, severe protein energy malnutrition, diabetes
or hypertension and those with hepatic damage were not included in the
trial.
Chemotherapeutic regimens :The patients were allocated at random
to receive one of the following two regimens:
A H C D  : Clofazimine (C) and Diamino-diphenyl-sulphone (D) daily
for 12 months, with the addition of pheniramine maleate
(AH) daily for the first 3 months.
CD : Clofazimine and Diamino-diphenyl-sulphone daily for
12 months, with the addition of a calcium lactate tablet
daily for the first 3 months.
500
THOMAS ET AL—ROLE OF ANTI-HISTAMINES IN THE TREATMENT OF LEPROSY
The study was conducted double-blind to avoid any possibility of
bias. Thus neither the doctors, clinic staff and para-medical workers nor
the patients knew whether an individual patient was receiving the anti-
histamine or the calcium lactate tablet. Each day’s drugs for the first 3
months for each patient were pre-packed at the Tuberculosis Research
Centre, Madras.
Clofazimine and DDS were given in a dose of 100 mg daily, anti-his-
tamine 50 mg daily and a matching tablet of calcium lactate.
All the drugs were given daily in a single dose.The drugs were ad-
ministered under supervision during the first 3 months.Duri g 4-12 months,
patients being treated at the Govt. Royapettah Hospital attended twice a
week, received that day’s drugs under supervision, and collected drugs for
the rest of the days for self-administration.For patients in the villages, a
paramedical worker visited the house of each patient daily in the first 3 months
to administer the drugs under supervision, and weekly during the following
9 months to supply drugs for self-administration.
Allocation of treatment regimens : The patients were randomly
allocated to the above two treatment regimens at the Tuberculosis Re-
search Centre, Madras, after stratification according to the history of pre-
vious anti-leprosy chemotherapy as (a) less than one year, (b) 1 to 5 years,
and (c) more than 5 years.
Assessments and examinations
(a) On admission :All the patients underwent (i) a general medical
checkup to exclude other health problems, (ii) clinical assessment of leprosy,
(iii) examination of skin smears from six active sites for lepra bacilli to de-
termine the bacteriological index (BI) and morphological index (MI), (iv)
estimation of haemoglobin and total and differential white blood cells counts,
(v) urine tests for albumin and sugar, (vi) Mitsuda lepromin test, (vii) skin
biopsy for histopathological examination, and (viii) colour transparencies
of lesions.
In addition, a clinical examination for leprosy was undertaken on
admission by an independent assessor, who was unaware of the treatment
regimen and the bacteriological findings.
(b) During treatment :The clinical, bacteriological, blood and urine
examinations were undertaken every three months. All the patients were
clinically examined by the independent assessor and clinical photographs
were taken at 3, 6 and 12 months.
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RESULTS
Study population :In all, 120 patients were admitted to the trial.
Of these, 17 patients were excluded; 2 patients died of causes unrelated to
leprosy (one with burns and the other of cardio-pulmonary failure) and 15
patients (7 AHCD, 8 CD) becameunto-operative and discharged them-
selves against medical advice (10 patients stopped attending during the first
3 months, 3 during 4-6 months and 2 in 9-12 months).Thus there remained
103 patients (52 AHCD, 51 CD) for analysis.
Of the 103 patients, 89 were males; 38 patients were under 30 years
of age, 29 were aged 30-39 years, and the reamining 36 were aged 40 years
or more. The mean age was 34 years (range 15-65 years) and the mean
weight 44.5 kg (range 29.2-83.3 kg). All the 103 patients gave a history
of previous dapsone monotherapy for periods of less than one year (40),
1 to 5 years (29), and more than 5 years (34).
In all, 88 patients had histopathology findings; 62 (32 AHCD, 30 CD)
(70 %) were classified as lepromatous, 13 (4 AHCD, 9 CD) (15 %) as bor-
derline lepromatous and 13 (7 AHCD, 6 CD) (15 %) as indeterminate.
Drug regularity :A total of 27 (52%) patients in the AHCD regi-
men and 23 (45%) patients in the CD regimen did not miss a single dose
during the first 3 months; the remaining 25 (48%) patients in the AHCD
and 28 (55%) patients in the CD regimen received 80-99% of the scheduled
chemotherapy. Over the period of 12 months, 13 (25%) patients in the
AHCD and 12 (24%) patients in CD regimen did not miss a single dose
38 (73%) patients in the AHCD and 38 (75%) patients in the CD regimen
received 80-99% and 1 patient in each regimen had less than 80% (78%
and 77%) of their scheduled chemotherapy. Thus the regularity in the 2
regimens was similar.
Clinical progress :The independent assessor classified as having
moderate or marked clinical improvement 36 (69%) AHCD and 33 (65%)
CD patients at 3 months, 81% and 88% at 6 months, and 92% and 86%
at 12 months, respectively. Thus the clinical improvement was similar in
the 2 regimens.
Bacterial indices : The mean BI was high and similar at the time of
admission, viz., 4.1 for AHCD and 4.2 for CD patients. There was a steady
fall in the BI values, the fall being 0.2 by 3 months, 0.3 by 6 months and
0.7 by 12 months for the AHCD regimen; the corresponding figures for the
CD regimen were 0.2, 0.4 and 0.9.Thus the reduction was similar in the
2 regimens.
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Morphological indices :The morphological indices (Ml) were
determined for 54 patients;a high proportion of the patients had
low MI.
ENL reactions during treatment :Of the 103 patients, 42 (19 AHCD,
23 CD) had ENL reactions.The incidence of reactions was similar in the
two regimens. The reactions were controlled with chloroquine, anti-his-
tamines, analgesics, prednisolone and/or thalidomide, the chemotherapy
being continued.
DISCUSSION
The study presented in this report was conducted to elucidate the role
of anti-histamines in the treatment of bacilliferous lepromatous leprosy
cases, having been designed to avoid bias at any stage. Gangadhara Sharma
(1982) had reported marked clinical and bacteriological improvement on
concurrent administration of pheniramine maleate with anti-leprotic drugs
in lepromatous leprosy patients.However, there were no controls who
had not received the anti-histamine supplement.The fi dings of the present
study do not confirm the findings of the above study.
Several workers have investigated the role of histamine and anti-
histamines in mycobacterial infection.Increased levels of histamine and
histaminases in tuberculosis and lepromatous leprosy cases were reported
by Rai et al. (1977). Kato (1957) reported immunosuppression with anti-
histamines in guinea-pigs infected with M. lepraemurium.However, the
findings were not corroborated by Kirchheimer (1964).Veeraraghavan
(1983) had reported growth-promoting effect with the addition of hista-
mine to culture media used for in vitro cultivation of M. leprae which was
not substantiated by Prabhakar et l. (1983) and Katoch and Desikan
(1983). Furthermore, though histamine could induce suppressor T-cells
in vitro as observed by Nanda and Nath (1982), it probably does not alter
the delayed type of hypersensitivity response to M. l prae (Guimaraes,
1961). Converse et al. (1987) have recently reported that administration
of Cimetidine abolished the suppressive effect of mediators released by
mononuclear cells from lepromatous leprosy patients. However, the the-
rapeutic implication of this observation needs to be established. Thus it
may be seen that several observations regarding the possible beneficial
effect with anti-histamines in the treatment of leprosy have been report-
ed which were not substantiated subsequently by other workers, and many
hypotheses purported need to be confirmed by conducting meticulously
designed studies.
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